UCN‐01, an anti‐tumor drug, is a selective inhibitor of the conventional PKC subfamily
Keiko Mizuno(Juntendo University Nerima Hospital), Shigeo Ohno(Juntendo University), Shin‐Ichi Osada(Nippon Medical School), Hisao Hanaki(Yokohama City University), Syu-ichi Hirai(Wakayama University), Toshio Kuroki(Japan Society for the Promotion of Science), Yoshihiko Ueda(Dokkyo Medical University Saitama Medical Center), Tatsuya Tamaoki(Kyowa Kirin (Japan)), Takaomi C. Saido(RIKEN Center for Brain Science), Kumi Nöda(Yokohama City University), Tohgo Ikuta(Tokyo University of Science)
Cited by 78
Related Papers
The Major Risk Factors for Alzheimer’s Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaques
|Cell Reports|2019|978
<scp>APP</scp> mouse models for Alzheimer's disease preclinical studies
|The EMBO Journal|2017|780
Production of hydrogen peroxide by transforming growth factor-beta 1 and its involvement in induction of egr-1 in mouse osteoblastic cells.
|The Journal of Cell Biology|1994|471